Brain bleed breakdown: could a common seizure pill boost recovery?
NCT ID NCT07336992
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving the seizure medicine levetiracetam right after a brain bleed (intracerebral hemorrhage) can prevent seizures and improve long-term recovery. About 580 adults will receive either the drug or a placebo for up to 7 days, and their level of disability will be checked 6 months later. The goal is to see if preventing early seizures leads to better function and quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPONTANEOUS INTRACEREBRAL HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospices Civils de Lyon
Bron, 69500, France
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gentle surgical approach improve outcomes after deep brain bleeding?
- Could common drugs curb brain bleed aftermath?
- AI could revolutionize bleeding stroke diagnosis and prognosis
- Could a common MS drug help stroke patients? new trial begins
- Digital tool aims to ease end-of-life planning for caregivers